• Home
  • About Us
  • Blog

Pulmonary Hypertension RN

  • What is Pulmonary Hypertension?
    • What is Pulmonary Hypertension?
    • Pulmonary Hypertension Symptoms
    • Types of Pulmonary Hypertension
    • Causes of Pulmonary Hypertension
    • PH vs. PAH
    • Diastolic Heart Failure vs. PAH
    • WHO Group 3 Pulmonary Hypertension, IPF & COPD
    • Pulmonary Veno-Occlusive Disease
    • Hereditary Hemorrhagic Telangiectasia (HHT)
      • Hereditary Hemorrhagic Telangiectasia (HHT) Treatment
    • Functional Classification of Pulmonary Hypertension
    • Congenital Heart Disease
      • Eisenmenger’s Syndrome
      • Update on Management of PAH-CHD
      • Congenital Heart Disease & Sleep Apnea
      • Complex Congenital Heart Disease
      • Atrial Septal Defect and Pulmonary Arterial Hypertension
    • Pediatric Pulmonary Arterial Hypertension
    • Sickle Cell and Pulmonary Hypertension
    • Stimulant Associated Pulmonary Arterial Hypertension
    • Porto-Pulmonary Syndrome
    • Research, Life Expectancy & Prognosis for PH
  • Diagnosing & Monitoring PAH
    • Pulmonary Arterial Hypertension Diagnosis
    • How Am I Doing? Assessing Your PAH.
    • Blood Tests
    • Cardiopulmonary Exercise Test (CPET)
    • CT (Computed Tomography) Scan
    • Echocardiogram: An Overview
    • Echocardiogram: A Detailed Look
    • Pulmonary Function Tests (PFTs)
    • Right Heart Catheterization
    • Six Minute Walk
    • Ventilation Perfusion Scan (VQ Scan)
    • CTEPH
      • CTEPH: WHO Group 4 Pulmonary Hypertension
      • PTE (Pulmonary Thromboendarterectomy) Surgery
      • Adempas used to Treat PAH and CTEPH
  • PAH Treatment
    • Pulmonary Hypertension Centers
    • Pulmonary Hypertension Treatments
    • Continuously Infused Therapies Used to Treat PH
    • Prostanoids for Treatment of PH
    • Adcirca and Revatio Used to Treat Pulmonary Arterial Hypertension (PAH)
    • Adempas used to Treat PAH and CTEPH
    • Tracleer, Letairis, and Opsumit Treatments
    • Oxygen Therapy for Pulmonary Hypertension
    • Salt and Water Restrictions
    • Exercise & PAH
    • Diuretics
    • Blood Thinners
    • Getting the Most Out of PAH Therapy
      • Letairis
      • Opsumit
      • Sildenafil (Revatio)
  • Research
  • FAQ’s
    • Implanted Remodulin Pump, Right Heart Catheterization, PAH & Pregnancy
    • Oral Treatments, Care Centers & Hole in Heart
    • FAQ’s: Altitude, Cold & Allergy Medications
    • FAQ’s: Psoriasis, Idiopathic PAH, Contraceptives & PAH
    • FAQ’s: Causes of Pulmonary Hypertension, Symptom Frequency & Care Centers
    • FAQ: PAH Experts, Pregnancy, Mild PAH & Vacationing
    • FAQ’s: CTEPH, Blood Clots, Corrective Surgery & PAH Care Centers
    • FAQ’s: VQ Scans & PAH Curable?
    • FAQ’s: Mild Pulmonary Hypertension?
    • FAQ’s: Boating, Swimming & Eating with PAH
    • FAQ’s: Borderline Pulmonary Hypertension, Hand Swelling, Children with PAH, Costs

Orenitram Now Available To Treat PAH

July 3, 2014 By Dr. Jeremy Feldman

PAH Expert talking with PH patient

Orenitram (trepostinil), fondly referred to by some as oral Remodulin, was approved by the FDA to treat PAH in December 2013 and is now available by prescription to the public. … [Read more...]

PAH and Diuretics

May 28, 2014 By Dr. Jeremy Feldman

Swelling in ankles of PH patient

Let’s Talk About Diuretics (Medicines That Make Your Kidneys Produce More Urine). One of the major problems in PAH is that patients retain fluid. That means that all of the salt and fluids you drink are not adequately eliminated by your kidneys. … [Read more...]

Anticoagulation and Pulmonary Arterial Hypertension

May 13, 2014 By Dr. Jeremy Feldman

PAH patient

A common questions that comes up in caring for patients with PAH is whether they should be prescribed blood thinners such as warfarin or Coumadin. The answer to this question is a bit complicated. … [Read more...]

National Nurses Day is May 6th!

May 1, 2014 By Dr. Jeremy Feldman

Thank a PH Nurse

May 6th is National Nurses Day!  Hopefully if you or a loved one has been diagnosed with PAH you have also been introduced to a Pulmonary Hypertension Nurse Coordinator. … [Read more...]

Updates on Opsumit and Adempas; New Treatments for PAH

April 16, 2014 By Dr. Jeremy Feldman

Update on PAH Treatments

In October 2013 the FDA approved Opsumit (Macitnentan) and Adempas (Riociguat) to treat pulmonary arterial hypertension.  Adempas was the first medication approved to treat two kinds of pulmonary hypertension.  It can be used to treat pulmonary arterial hypertension as well as chronic thromboembolic pulmonary hypertension. … [Read more...]

« Previous Page
Next Page »

PAH Life Expectancy

PAH Research

Research, Life Expectancy & Prognosis for PH

Major Developments in Pulmonary Hypertension Affecting Prognosis 1.     Approval of

Where to Get Treatment?

CCCs for PAH

Pulmonary Hypertension Centers

Where to get treatment for pulmonary hypertension? Pulmonary arterial hypertension is a

Popular Posts

Massachusetts Pulmonary Hypertension Task Force

Massachusetts – First State to Create PAH Task Force

By Dr. Jeremy Feldman

  The first PAH State Task Force has been created in Massachusetts. The purpose of the force is to monitor

PH Support Group

3 Benefits of Pulmonary Hypertension Support Groups

By Dr. Jeremy Feldman

A pulmonary hypertension support group is a group of patients with PAH coming together to learn about and support

good news in pah

 

Disclaimer

Recent Blog Posts

  • In Memoriam:  Greg Ahearn, MD June 16, 2024
  • Sotatercept (Winrevair) Approved! June 1, 2024
  • Disappointing News for Rodatristat Ethyl October 11, 2023

Categories

Archives